Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes

Jun Zhang*, D. Ware Branch, Mildred M. Ramirez, S. Katherine Laughon, Uma Reddy, Mathew Hoffman, Jennifer Bailit, Michelle Kominiarek, Zhen Chen, Judith U. Hibbard

*Corresponding author for this work

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

To examine the effects and safety of high-dose (compared with low-dose) oxytocin regimen for labor augmentation on perinatal outcomes. Data from the Consortium on Safe Labor were used. A total of 15,054 women from six hospitals were eligible for the analysis. Women were grouped based on their oxytocin starting dose and incremental dosing of 1, 2, and 4 milliunits/min. Duration of labor and a number of maternal and neonatal outcomes were compared among these three groups stratified by parity. Multivariable logistic regression and generalized linear mixed model were used to adjust for potential confounders. Oxytocin regimen did not affect the rate of cesarean delivery or other perinatal outcomes. Compared with 1 milliunit/min, the regimens starting with 2 milliunits/min and 4 milliunits/min reduced the duration of first stage by 0.8 hours (95% confidence interval 0.5-1.1) and 1.3 hours (1.0-1.7), respectively, in nulliparous women. No effect was observed on the second stage of labor. Similar patterns were observed in multiparous women. High-dose regimen was associated with a reduced risk of meconium stain, chorioamnionitis, and newborn fever in multiparous women. High-dose oxytocin regimen (starting dose at 4 milliunits/min and increment of 4 millliunits/min) is associated with a shorter duration of first-stage of labor for all parities without increasing the cesarean delivery rate or adversely affecting perinatal outcomes. II.

Original languageEnglish (US)
Pages (from-to)249-256
Number of pages8
JournalObstetrics and gynecology
Volume118
Issue number2
DOIs
StatePublished - Aug 2011

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes'. Together they form a unique fingerprint.

  • Cite this

    Zhang, J., Branch, D. W., Ramirez, M. M., Laughon, S. K., Reddy, U., Hoffman, M., Bailit, J., Kominiarek, M., Chen, Z., & Hibbard, J. U. (2011). Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes. Obstetrics and gynecology, 118(2), 249-256. https://doi.org/10.1097/AOG.0b013e3182220192